Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest close session, Oscar Health, Inc. (OSCR) was down 1.26% at $14.84. This change lagged the S&P 500's daily gain of 0.46%. On the other hand, the Dow registered a gain of 0.17%, and the technology-centric Nasdaq increased by 0.57%. The company's shares have seen a decrease of 8.85% over the last month, not keeping up with the Finance sector's gain of 5.73% and the S&P 500's gain of 4.22%.Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is expected to report EPS of -$0.84, down 35.48% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.21 billion, indicating a 33.98% increase compared to the same quarter of the previous year. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$1.35 per share and revenue of $12.1 billion. These totals would mark changes of -1450% and +31.86%, respectively, from last year. Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 2.88% rise in the Zacks Consensus EPS estimate. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #3 (Hold). The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 44, placing it within the top 18% of over 250 industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks